Search
for
Sort by
Research 631–660 of 1000+
- Helicobacter pylori infection and skin disorders
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Cutaneous manifestations of chronic kidney disease - A cross sectional study
- Comparative study of cutaneous manifestations in patients with chronic kidney disease , patients on haemodialysis, and renal transplant recipients
- Cutaneuos findings in patients with predialysis chronic kidney disease
- The Role of Zinc in Gastrointestinal and Liver Disease
- The role of WNT10B in physiology and disease: A 10-year update
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- New Pharmaceutical Concepts for Sebaceous Gland Diseases: Implementing Today’s Pre-Clinical Data into Tomorrow’s Daily Clinical Practice
- Approach to Patients with Suspected Rheumatic Disease
- Cutaneous extramedullary haematopoiesis: Implications in human disease and treatment
- Does an apple a day keep away diseases? Evidence and mechanism of action
- The Roles of EDA2R in Ageing and Disease
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Microneedling for Cutaneous Manifestations of Autoimmune Disease: A Scoping Review
- Do Dermatoses Trigger Neurodegenerative Diseases? A Retrospective Observational Study
- Evaluation of clinical and lifestyle factors associated with disease severity in adult patients with scalp seborrheic dermatitis
- Nutraceutical : An emerging Pharmaceutical Towards Prevention Of Diseases
- Disorders of the skin appendages
- Cocaine-related bullous disease
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Besnoitiosis in donkeys: an emerging parasitic disease of equids in Italy
- Achievement of good long-term control with direct oral anticoagulant for Buerger’s disease
- 265 Modulation of disease-central cytokine pathways with TAK-279, a highly selective oral tyrosine kinase 2 (TYK2) inhibitor, defines clinical response in patients with psoriasis
- Dermatological manifestations in patients with chronic kidney disease
- Prevention of Murine Sclerodermatous Chronic Graft-Versus-Host Disease by Rapamycin
- Research Status of Oily Skin and the Use of Appropriate Technical Methods with Traditional Chinese Medicine Characteristics
- SAT-130 Estrogen deficiency in patients with reduced fat mass as a cause of non-alcoholic fatty liver disease
- Vogt-Koyanagi-Harada Disease Diagnosed in a Black-Skinned Woman in Internal Medicine